Cysteine derivative and synthesis method thereof
A technology of cysteine and a synthetic method, applied in the field of amino acid and preparation thereof, can solve the problems of expensive mass production and use of metal palladium, unpleasant smell of thiol, expensive reaction raw materials, etc., and achieves low cost, high yield, and method. Simple and easy effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] In this example, product 1 was synthesized with N-benzyloxycarbyl-protected cysteine and methyl p-bromobenzoate as raw materials, and its structural formula is:
[0028]
[0029] In this embodiment, a synthetic method of cysteine derivatives, the steps are as follows:
[0030] To a dry Schlenk tube, add N-benzyloxycarbyl-protected cysteine (0.03mmol, 80.7mg, 100mol%), methyl p-bromobenzoate (0.032mmol, 68.8mg, 110mol%), zinc powder (0.06 mmol, 39mg, 200mol%), anhydrous magnesium chloride (0.03mmol, 28.6mg, 100mol%), Ni(acac) 2 (0.003mmol, 7.7mg, 10mol%), 4-dimethoxybipyridine (0.0045mmol, 0.0148g, 15mol%), and finally DMSO1ml was added by syringe, and stirred at room temperature for 8-12h. After the reaction, the colorless liquid 1 can be obtained by directly separating by column chromatography (ethyl acetate:petroleum ether=2:8) without post-treatment, and the yield is 90-95%.
[0031] The product 1 synthesized by the method of this embodiment is characteriz...
Embodiment 2
[0035] This embodiment is basically the same as Embodiment 1, especially in that:
[0036] In this example, product 2 was synthesized using N-benzyloxycarbonyl-protected cysteine and 4-trifluoromethylbromobenzene as raw materials, and its structural formula is:
[0037]
[0038] In this embodiment, a synthetic method of cysteine derivatives, the steps are as follows:
[0039] To a dry Schlenk tube, add N-benzyloxycarbyl-protected cysteine (0.03mmol, 80.7mg, 100mol%), 4-trifluoromethylbromobenzene (0.032mmol, 72mg, 110mol%) zinc powder ( 0.06mmol, 39mg, 200mol%), anhydrous magnesium chloride (0.03mmol, 28.6mg, 100mol%), Ni(acac) 2 (0.003mmol, 7.7mg, 10mol%), 4-dimethoxybipyridine (0.0045mmol, 0.0148g, 15mol%), and finally DMSO1ml was added by syringe, and stirred at room temperature for 8-12h. After the reaction, the yellow solid 2 can be obtained directly by column chromatography (ethyl acetate:petroleum ether=2:8) without post-treatment, and the yield is 83-88%.
...
Embodiment 3
[0044] This embodiment is basically the same as the previous embodiment, and the special features are:
[0045] In this example, product 3 was synthesized with N-benzyloxycarbonyl-protected cysteine and 4-bromobenzaldehyde as raw materials, and its structural formula is:
[0046]
[0047]In this embodiment, a synthetic method of cysteine derivatives, the steps are as follows:
[0048] To a dry Schlenk tube, add N-benzyloxycarbonyl-protected cysteine (0.03mmol, 80.7mg, 100mol%), 4-bromobenzaldehyde (0.032mmol, 59.2mg, 110mol%), zinc powder (0.06mmol , 39mg, 200mol%), anhydrous magnesium chloride (0.03mmol, 28.6mg, 100mol%), Ni(acac) 2 (0.003mmol, 7.7mg, 10mol%), 4-dimethoxybipyridine (0.0045mmol, 0.0148g, 15mol%), and finally DMSO 1ml was added by syringe, and stirred at room temperature for 8-12h. After the reaction, the white solid 3 can be obtained by direct column chromatography (ethyl acetate:petroleum ether=2:8) without post-treatment, and the yield is 70-75%. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


